1-Hydroxy-3-Isopentoxybenzene

1-Hydroxy-3-Isopentoxybenzene

SCHEMBL2850085

CC(C)CCOc1cccc(O)c1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.60
CHRNA4 P43681 1/20 0.60
GALR3 O60755 1/20 0.49
HSP90AA1 P07900 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
DRD2 P14416 1/20 0.49
DRD4 P21917 1/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49
DRD3 P35462 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPK1 P28482 1/20 0.47
APP P05067 1/20 0.47
EPHX2 P34913 1/20 0.45
PDK2 Q15119 1/20 0.45
CYP3A4 P08684 1/20 0.44
CHRNB4 P30926 2/20 0.44
CHRNA3 P32297 2/20 0.44
OPRM1 P35372 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11574802 0.91 CHRNB2 (0.58) CHRNB2CHRNA4DRD2DRD4ADRA1D
SCHEMBL1402253 0.88 CHRNB2 (0.55) CHRNB2CHRNA4NR1H4DRD2DRD4
SCHEMBL1402311 0.88 CHRNB2 (0.55) CHRNB2CHRNA4NR1H4DRD2DRD4
SCHEMBL28737185 0.88 CHRNB2 (0.58) CHRNB2CHRNA4DRD2DRD4ADRA1D
1,3-Diisopentoxybenzene SCHEMBL2846359 0.87 TDP1 (0.57) GALR3HSP90AA1NR1H4TDP1MAPK1
SCHEMBL27717865 0.84 CHRNB2 (0.57) CHRNB2CHRNA4DRD2DRD4ADRA1D
SCHEMBL29510932 0.82 CHRNB2 (0.69) CHRNB2CHRNA4DRD2DRD4ADRA1D
SCHEMBL1470185 0.82 CHRNB2 (0.69) CHRNB2CHRNA4DRD2DRD4ADRA1D
SCHEMBL27933883 0.82 CHRNB2 (0.53) CHRNB2CHRNA4GALR3HSP90AA1DRD2
SCHEMBL3164505 0.81 CHRNB2 (0.54) CHRNB2CHRNA4NR1H4MAPK1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200223871-A1 Arginase Inhibitors and Methods of Use ASTRAZENECA AB (SE) 2020-07-16 US disclosed
US-9497963-B2 Methods and compositions for control of gypsy moth, Lymantria dispar SIMON FRASER UNIVERSITY (CA) 2016-11-22 US disclosed
US-9125406-B2 Methods and compositions for control of cabbage looper, trichoplusia ni SIMON FRASER UNIVERSITY (CA) 2015-09-08 US disclosed
US-20130131185-A1 Methods and Compositions for Control of Cabbage Looper, Trichoplusia ni THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2013-05-23 US disclosed
US-20130045178-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar SIMON FRASER UNIVERSITY (CA) 2013-02-21 US disclosed
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR SIMON FRASER UNIVERSITY (CA) 2010-11-25 US disclosed
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US disclosed
US-20100160451-A1 METHODS AND COMPOSITIONS FOR CONTROL OF CABBAGE LOOPER, Trichoplusia ni SIMON FRASER UNIVERSITY (CA) 2010-06-24 US disclosed
EP-0341664-B1 SKIN DEPIGMENTAL AGENT KURARAY CO., LTD. (JP) 1992-08-05 EP disclosed
US-4959393-A ALKYL-SUBSTITUTED RESORCINOL KURARAY COMPANY, LTD. (JP) 1990-09-25 US disclosed
EP-0341664-A1 Skin depigmental agent KURARAY CO., LTD. (JP) 1989-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223871-A1 Arginase Inhibitors and Methods of Use ARG1, ARG2, NOS2 CHRNB2 1704/4885CHRNA4 2881/4885GALR3 1455/4885
US-20130131185-A1 Methods and Compositions for Control of Cabbage Looper, Trichoplusia ni CDV3, ETV1, BOLA2; BOLA2B CHRNB2 1965/4885CHRNA4 1504/4885GALR3 2122/4885
US-20130045178-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar L3MBTL3, L3MBTL4, L3MBTL1 CHRNB2 446/4885CHRNA4 902/4885GALR3 14/4885
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 CHRNB2 559/4885CHRNA4 1174/4885GALR3 13/4885
US-20100160451-A1 METHODS AND COMPOSITIONS FOR CONTROL OF CABBAGE LOOPER, Trichoplusia ni CDV3, ETV1, TMSB4X CHRNB2 1828/4885CHRNA4 1326/4885GALR3 2076/4885
US-20100297059-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR L3MBTL3, L3MBTL4, L3MBTL1 CHRNB2 544/4885CHRNA4 1151/4885GALR3 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.